Showing 62 companies
At Animal Dynamics they know that nature’s evolved designs are more efficient, elegant and powerful than anything yet built by man. However, the last decade has seen revolutions in analytical technology that allow us to evaluate high-performance animals to a previously unachievable degree, and use cutting-edge science to understand the fundamental mechanisms underlying this performance. At Animal Dynamics we don't simply attempt to replicate the high-performance natural designs, but marrie fine-engineering skills with a deep understanding of the fundamental mechanisms to produce revolutionary machines that will change the shape of the future. Taking our inspiration from animals and the natural world, we can achieve significant improvements in the performance and efficiency of vehicles in water, air, and ground travel. What motivates us is our desire to create original and worthwhile solutions to real problems. We are motivated to realise designs that will positively disrupt industries and technical approaches that have long been taken for granted.
Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The company was founded on pioneering research from the University of Oxford, UK. Argonaut strives to develop a new class of precision cancer medicines which target the enzymes responsible for abnormal arginine methylation in cancer.
Bodle Technologies is developing SRD®, the world’s first solid-state reflective display technology, based on phase-change materials. Providing vivid colour and video-capability, with zero energy use for static image storage, the technology is ideally suited to address the issues of poor outdoor readability and high power consumption associated with transmissive and emissive displays.
Caristo Diagnostics has been formed to bring revolutionary cardiovasular diagnostic tools to patients worldwide. Our proprieraty technology transforms the accuracy of routine cardiac CT scans by extracting new information that is otherwise invisible, greatly enhancing the power to predict cardiovascular risk and refine treatment decisions.
Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and investors. The world-leading science generated by its academic founders is the foundation for the development of therapeutic products based on the understanding of the molecular control of circadian rhythms. With an experienced leadership team and a track-record of building operational capabilities and delivering shareholder value, the Company will develop therapeutics targeting serious diseases associated with circadian rhythm disruption.
Covatic creates the tech, data and tools to drive targeted and engaging in-app experiences on mobile devices while maintaining an absolute guarantee of user privacy. Using integrated proprietary technology within a host app, Covatic is able to provide users with contextualised, timely content, advertisements and messages based on their known behaviours and preferences. This ensures communication is impactful and effective, driving engagement, acquisition and retention. Covatic is a fast-growing Techstars backed technology company based in Birmingham, UK.
DeepReason.ai – a spinout from Oxford University's Computer Science department – offers a powerful Enterprise Knowledge Graph Platform, with 4 key differentiators: 1) It unifies knowledge across siloed enterprise data, without data migration, 2) It provides an audit trail for decisions: contributing factors, data source, and certainty, 3) It provides a rich AI language to reason over domain knowledge & business rules, 4) It has an open architecture: integrates with Machine Learning and connects to ontologies & data workflows.